DMAAU

Drugs Made In America Acquisition
$11.00
$0.00 (0%)Oct 29, 2026
Return+8.8%5YRange $10.10 - $11.32
$11.5$11.0$10.5$10.0Feb 25Dec 25Oct 26

Key metrics

The numbers that frame DMAAU today
52wk Low
$10.30
52wk High
$12.50

DMAAU stock rating

How DMAAU scores on quality, value, growth, momentum and financial health
-out of 10
No overall ratingHealthy business, valuation unclear
Quality-
Growth-
Momentum6.3
Value-
Financial Health-

Growth

Revenue and earnings trend for DMAAU
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about DMAAU
Is Drugs Made In America Acquisition a good buy?
Yes. Drugs Made In America Acquisition has strong momentum.
What is the 52-week high for DMAAU stock?
The 52-week high for Drugs Made In America Acquisition is $12.50. The current close of $11.00 is 12% below that high.
What is the 52-week low for DMAAU stock?
The 52-week low for Drugs Made In America Acquisition is $10.30. The current close of $11.00 is 6.8% above that low.